0
Research Papers

Development and Evaluation of Drug Eluting Stent Having Biphasic Release From a Single Layer of Biodegradable Polymer

[+] Author and Article Information
Ramila Mandal

Sahajanand Medical Technologies Pvt. Ltd.,
Surat, India

Sanjay Parmar

L. M. College of Pharmacy,
Ahmedabad, India

Jaynish Tailor

Sahajanand Medical Technologies Pvt. Ltd.,
Surat, 395004, India

Anita Mehta

L. M. College of Pharmacy,
Ahmedabad, 380009, India

Manuscript received August 13, 2012; final manuscript received December 18, 2012; published online February 4, 2013. Assoc. Editor: Paul A. Iaizzo.

J. Med. Devices 7(1), 011005 (Feb 04, 2013) (5 pages) Paper No: MED-12-1102; doi: 10.1115/1.4023414 History: Received August 13, 2012; Revised December 18, 2012

In stent restenosis is the major disadvantage of percutaneous transluminal angioplasty. To overcome this limitation, drug eluting stents were introduced. We have developed novel sirolimus eluting stent using biocompatible and biodegradable polymer matrix. Developed stent have biphasic release profile for sirolimus from a single layer of polymer matrix, having blend of slow and fast degrading polymers. Coating integrity of coated stents were evaluated after crimping and postexpansion with the help of scanning electron microscopy while thickness of coated stent was measured using destructive test method. This shows that drug-polymers bilayer was uniformly coated with the average thickness of 5.2 μms. There was no deformation after crimping and expansion of the stent. We have also measured in vitro and in vivo release profiles of sirolimus from stents which shows biphasic release characteristics, i.e., initial burst period followed by sustained release. In vitro release profile is well correlated with in vivo release in blood and arterial tissues. Developed stents showed good efficacy and safety in porcine coronary artery model.

FIGURES IN THIS ARTICLE
<>
Copyright © 2013 by ASME
Your Session has timed out. Please sign back in to continue.

References

Garcia-Garcia, H. M., Vaina, S., Tsuchida, K., and Serruys, P. W., 2006, “Drug-Eluting Stents,” Arch. Inst. Cardiol. Mex, 76(3), pp. 297–319.
Daemen, J., and Serruys, P. W., 2007, “Drug-Eluting Stent Update 2007—Part I: A Survey of Current and Future Generation Drug-Eluting Stents: Meaningful Advances or More of the Same?,” Circulation, 116(3), pp. 316–328. [CrossRef] [PubMed]
Venkatraman, S., and Boey, F., 2007, “Release Profiles in Drug-Eluting Stents: Issues and Uncertainties,” J. Controlled Release, 120(3), pp. 149–160. [CrossRef]
Kukreja, N., Onuma, Y., Daemen, J., and Serruys, P. W., 2008, “The Future of Drug-Eluting Stents,” Pharmacol. Res., 57(3), pp. 171–180. [CrossRef] [PubMed]
Tsuji, T., Tamai, H., Igaki, K., Kyo, E., Kosuga, K., Hata, T., Nakamura, T., Fujita, S., Tekeda, S., Motohara, S., and Uehata, H., 2003, “Biodegradable Stents as a Platform to Drug Loading,” Cardiovasc. Intervent Radiol.,5(1), pp. 13–16. [CrossRef]
Dani, S., Kukreja, N., Parikh, P., Joshi, H., Prajapati, J., Jain, S., Thanvi, S., Shah, B., and Dutta, J.-P., 2008, “Biodegradable-Polymer-Based, Sirolimus-Eluting Supralimus Stent: 6-Month Angiographic and 30-Month Clinical Follow-Up Results From the Series I Prospective Study,” EuroIntervention, 4(1), pp. 59–63. [CrossRef] [PubMed]
Han, Y., Jing, Q., Xu, B., Yang, L., Liu, H., Shang, X., Jiang, T., Li, Z., Zhang, H., Li, H., Qiu, J., Liu, Y., Li, Y., Chen, X., and Gao, R., 2009, “Safety and Efficacy of Biodegradable Polymer-Coated Sirolimus-Eluting Stents in “Real-World” Practice: 18-Month Clinical and 9-Month Angiographic Outcomes,” JACC: Cardiovasc. Intervent., 2(4), pp. 303–309. [CrossRef]
Higgins, S. C., Montgomery, G. H., Raptis, G., and Bovbjerg, D. H., 2008, “Effect of Pretreatment Distress on Daily Fatigue After Chemotherapy for Breast Cancer,” J. Oncol. Pract., 4(2), pp. 59–63. [CrossRef] [PubMed]
Peng, H. Y., Chen, M., Zheng, B., Wang, X. G., and HuoY., 2009, “Long-Term Effects of Novel Biodegradable, Polymer-Coated, Sirolimus-Eluting Stents on Neointimal Formation in a Porcine Coronary Model,” Int. Heart J., 50(6), pp. 811–822. [CrossRef] [PubMed]
Lao, L. L., Venkatraman, S. S., and Peppas, N. A., 2008, “Modeling of Drug Release From Biodegradable Polymer Blends,” Eur. J. Pharm. Biopharm., 70(3), pp. 796–803. [CrossRef] [PubMed]
Finkelstein, A., McClean, D., Kar, S., Takizawa, K., Varghese, K., Baek, N., Park, K., Fishbein, M. C., Makkar, R., Litvack, F., and Eigler, N. L., 2003, “Local Drug Delivery Via a Coronary Stent With Programmable Release Pharmacokinetics,” Circulation, 107(5), pp. 777–784. [CrossRef] [PubMed]
Balakrishnan, B., Dooley, J. F., Kopia, G., and Edelman, E. R., 2007, “Intravascular Drug Release Kinetics Dictate Arterial Drug Deposition, Retention, and Distribution,” J. Control Release, 123(2), pp. 100–108. [CrossRef] [PubMed]
Guo, Q., Knight, P. T., and Mather, P. T., 2009, “Tailored Drug Release From Biodegradable Stent Coatings Based on Hybrid Polyurethanes,” J. Control Release, 137(3), pp. 224–233. [CrossRef] [PubMed]
Tesfamariam, B., 2008, “Drug Release Kinetics From Stent Device-Based Delivery Systems,” J. Cardiovasc. Pharmacol., 51(2), pp. 118–125. [CrossRef] [PubMed]
Rensing, B. J., Vos, J., Smits, P. C., Foley, D. P., Van den Brand, M. J. B. M., van der GiessenW. J., de Feijter, P. J., and Serruys, P. W., 2001, “Coronary Restenosis Elimination With a Sirolimus Eluting Stent,” Eur. Heart. J., 22, pp. 2125–2130. [CrossRef] [PubMed]
Udipi, K., Chen, M., Cheng, P., Jiang, K., Judd, D., Caceres, A., Melder, R. J., and Wilcox, J. N., 2008, “Development of a Novel Biocompatible Polymer System for Extended Drug Release in a Next-Generation Drug-Eluting Stent,” J. Biomed. Mater. Res. Part A, 85(4), pp. 1064–1071. [CrossRef]
Steigerwald, K., Merl, S., Kastrati, A., Wieczorek, A., Vorpahl, M., Mannhold, R., Vogeser, M., Hausleiter, J., Joner, M., Schömig, A., and Wessely, R., 2009, “The Pre-Clinical Assessment of Rapamycin-Eluting, Durable Polymer-Free Stent Coating Concepts,” Biomaterials30(4), pp. 632–637. [CrossRef] [PubMed]
Gourlay, S. J., Rice, R. M., Hegyeli, A. F., Wade, C. W., Dillon, J. G., Jaffe, H., and Kulkarni, R. K., 1978, “Biocompatibility Testing of Polymers: In Vivo Implantation Studies,” J. Biomed. Mater. Res., 12(2), pp. 219–232. [CrossRef] [PubMed]
Jain, R. A., 2000, “The Manufacturing Techniques of Various Drug Loaded Biodegradable Poly(lactide-co-glycolide) (PLGA) Devices,” Biomaterials, 21(23), pp. 2475–2490. [CrossRef] [PubMed]
Menke, H., Grubmeyer, H., Biemer, E., and Olbrisch, R. R., 2001, “PVP Breast Implants After Two Years: Initial Results of a Prospective Study,” Aesthetic Plast. Surg., 25(4), pp. 278–282. [CrossRef] [PubMed]
Daemen, J., and Serruys. P., 2007, “Drug Eluting Stent Update 2007—Part I: Survey of Current and Future Generation Drug-Eluting Stents: Meaningful Advances or More of the Same?,” Circulation, 116, pp. 316–328. [CrossRef] [PubMed]

Figures

Grahic Jump Location
Fig. 1

SEM images of stent in various situations. (a) SEM image of sterile crimped stent, (b) SEM image of sterile post-expansion stent, (c) SEM image of sterile normal stent.

Grahic Jump Location
Fig. 2

In vitro release of Sirolimus from the stents. In vitro release analysis of 11 mm, 16 mm, and 39 mm length stent shows similar type of release pattern.

Grahic Jump Location
Fig. 3

In vivo concentration of Sirolimus in tissue (ng/mg) and blood (ng/ml) at various time intervals after stent implantation. Sirolimus concentration in tissue shows biphasic release profile, i.e., initial burst release and then sustain release.

Grahic Jump Location
Fig. 4

% Cumulative concentration in blood versus % cumulative release in vitro of Sirolimus from 16 mm stent

Grahic Jump Location
Fig. 5

Histological sections of stented coronary arteries (a) developed stent and (b) BMS after eight weeks of implantation

Tables

Errata

Discussions

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging and repositioning the boxes below.

Related Journal Articles
Related eBook Content
Topic Collections

Sorry! You do not have access to this content. For assistance or to subscribe, please contact us:

  • TELEPHONE: 1-800-843-2763 (Toll-free in the USA)
  • EMAIL: asmedigitalcollection@asme.org
Sign In